Jason E. Stadanlick, Ph.D.
Affiliations: | 2008 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Immunology, Molecular Biology, Cell BiologyGoogle:
"Jason Stadanlick"Mean distance: 30533.1
Parents
Sign in to add mentorMichael P. Cancro | grad student | 2008 | Penn | |
(Tonic B cell antigen receptor signals supply an NF-kappa substrate, p100, for prosurvival BLyS signaling.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Volkov J, Nunez D, Mozaffar T, et al. (2024) Case study of CD19-directed chimeric antigen receptor T-cell therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis™ phase I/II trial. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Quinn WJ, Jiao J, TeSlaa T, et al. (2020) Lactate Limits T Cell Proliferation via the NAD(H) Redox State. Cell Reports. 33: 108500 |
Klampatsa A, O'Brien SM, Thompson JC, et al. (2019) Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes. Oncoimmunology. 8: e1638211 |
Singhal S, Stadanlick J, Annunziata MJ, et al. (2019) Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer. Science Translational Medicine. 11 |
Shilling D, Stadanlick JE, Meng W, et al. (2018) Oligoclonal Expansion of Cd8+ T Cells during Idiopathic Multicentric Castleman Disease Flares Suggests an Antigen Driven Process Blood. 132: 2411-2411 |
Predina JD, Newton AD, Connolly C, et al. (2017) Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Akimova T, Zhang T, Negorev D, et al. (2017) Human lung tumor FOXP+ Tregs upregulate four "Treg-locking" transcription factors. Jci Insight. 2 |
Solanki NR, Stadanlick JE, Zhang Y, et al. (2016) Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling. Journal of Immunology (Baltimore, Md. : 1950) |
Rao S, Cai KQ, Stadanlick JE, et al. (2016) Ribosomal protein Rpl22 controls the dissemination of T cell lymphoma. Cancer Research |
Rao S, Cai K, Stadanlick J, et al. (2015) Novel Role for Rpl22 in Controlling Lymphoma Progression and Dissemination Blood. 126: 3669-3669 |